Cargando…
5mC and H3K9me3 of TRAF3IP2 promoter region accelerates the progression of translocation renal cell carcinoma
BACKGROUND: In our previous study, we found that lncRNA TRAF3IP2 antisense RNA 1 (TRAF3IP2-AS1) could play a critical role in the progression of NONO-TFE3 translocation renal cell carcinoma (NONO-TFE3 tRCC). However, the function of TRAF3IP2 (TRAF3 interacting protein 2), encoded by the complementar...
Autores principales: | Yang, Lei, Chen, Yi, Liu, Ning, Lu, Yanwen, Li, Xin, Ma, Wenliang, Gan, Weidong, Li, Dongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331078/ https://www.ncbi.nlm.nih.gov/pubmed/35897085 http://dx.doi.org/10.1186/s40364-022-00402-3 |
Ejemplares similares
-
Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N(6)-methyladenosine of PARP1 mRNA and downregulating PTEN
por: Yang, Lei, et al.
Publicado: (2021) -
Correction to: Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N(6)-methyladenosine of PARP1 mRNA and downregulating PTEN
por: Yang, Lei, et al.
Publicado: (2021) -
Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma
por: Liu, Ning, et al.
Publicado: (2022) -
ChIP-seq profiling of H3K4me3 and H3K27me3 in an invasive insect, Bactrocera
dorsalis
por: Zhao, Yan, et al.
Publicado: (2023) -
Targeting TRAF3IP2 inhibits angiogenesis in glioblastoma
por: Izadpanah, Amin, et al.
Publicado: (2022)